“…These include lowering the risk of cardiovascular diseases (CVDs) (Babu et al, 2014;Nevin & Rajamohan, 2004) and Alzheimer's disease (Ramesh et al, 2021), being an antioxidant, showing anti-inflammatory activity (Illam et al, 2017;Karunasiri et al, 2020), decreasing blood sugar levels in diabetic patients and mice (Malaeb & Spoke, 2020;Zicker et al, 2019), and reducing body weight (Assunção et al, 2009;Cardoso et al, 2015). Several lines of evidence have demonstrated that the pharmacological benefits of VCO can be attributed to certain nutrients, for example, vitamin E and its bioactive polyphenol components, for example, gallic acid, ferulic acid, quercetin, methyl catechin, dihydrokaempferol, and myricetin glycoside (Illam et al, 2021(Illam et al, , 2017Ramesh et al, 2021;Zeng et al, 2022). The pharmacological actions of these polyphenols were widely reported in both in vitro (Illam et al, 2021(Illam et al, , 2017 and in vivo studies (Famurewa et al, 2021;Nevin & Rajamohan, 2004;Vysakh et al, 2014;Yeap et al, 2015).…”